FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097456 [Registered on: 14/11/2025] Trial Registered Prospectively
Last Modified On: 06/06/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Development and testing of a simple questionnaire to check how much people on regular dialysis know about fluid removal (ultrafiltration) and its possible problems. 
Scientific Title of Study   Development and validation of a questionnaire to assess the awareness regarding the ultrafiltration and related complications in individuals undergoing maintenance hemodialysis. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Akhilesh Hipparagi 
Designation  Student pursuing M.Sc. RRT&DT  
Affiliation  MCHP MAHE Manipal 
Address  Department of RRT and DT MCHP MAHE Manipal

Udupi
KARNATAKA
576104
India 
Phone  6361986829  
Fax    
Email  akhilesh.mchpmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ravindra Prabhu A 
Designation  Professor  
Affiliation  KMC MAHE Manipal  
Address  Department of Nephrology KMC MAHE Manipal

Udupi
KARNATAKA
576104
India 
Phone  9448107771  
Fax    
Email  ravindra.prabhu@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Megha Nagaraj Nayak 
Designation  Assistant Professor-selection Grade  
Affiliation  MCHP MAHE Manipal 
Address  Department of RRT and DT MCHP MAHE Manipal

Udupi
KARNATAKA
576104
India 
Phone  9482498153  
Fax    
Email  megha.nayak@manipal.edu  
 
Source of Monetary or Material Support  
Manipal Academy of Higher Education, Karnataka, Udupi, Manipal-576104, India. 
 
Primary Sponsor  
Name  Akhilesh Hipparagi 
Address  Department of RRT and DT, MCHP, MAHE, Karnataka, Udupi, Manipal-576104, India. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ravindra Prabhu A  Kasturba Medical College  Department of Nephrology, KMC, MAHE, Karnataka, Udupi, Manipal-576104, India.
Udupi
KARNATAKA 
9448107771

ravindra.prabhu@manipal.edu 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2  Approved 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee 2  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N186||End stage renal disease,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  5 members in the questionnaire development team. professionals with expertise related to the contents of the questionnaire. Experts will be from the following fields. Nephrologist or general physician and dialysis technology field expert or educator or academician. Expert in health data and information standards. On a need basis. One representative from patients or a caregiver will be recruited for this team. 5 members will be in the questionnaire validation team. This team will include experts from nephrology and dialysis technology and general medicine and statistics. Minimum five years of experience and willing to give informed consent. There will be no overlapping of members between the two teams.12 patients who have been undergoing maintenance hemodialysis for at least one year will be included. They must be able to read and understand english.  
 
ExclusionCriteria 
Details  Medical students or interns. Patients with psychiatric illness. A person is unable to read and write english.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
A content validated reliable and user friendly questionnaire in English.
 
Questionnaire development within 4 months. Validation of the questionnaire within 3 months. Face validity of the patients for 3 months.  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="22"
Sample Size from India="22" 
Final Enrollment numbers achieved (Total)= "140"
Final Enrollment numbers achieved (India)="140" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/11/2025 
Date of Study Completion (India) 05/06/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Patients with kidney failure who are on regular hemodialysis need to remove extra fluid from their bodies through a process called ultrafiltration. If this process is not properly managed, it can lead to health problems such as low blood pressure and cramp complications. Many patients may not have enough knowledge about how ultrafiltration works or how to prevent its complications.

This study aims to develop and validate a questionnaire that measures patient knowledge of ultrafiltration and its related issues. The questionnaire will first be developed and validated by collecting information from experts through semi structured interviews. Then it will be tested among patients on maintenance hemodialysis to ensure it is clear and accurate.

The results of this study will help healthcare professionals understand the level of awareness among dialysis patients and plan better education programs to improve patient safety and quality of life.

 
Close